4:11 PM ET
8-K
Business Update
Arcus Biosciences Business Update
Arcus Biosciences provided a preliminary estimate of its cash position, reporting approximately $694.0 million in cash, cash equivalents, and marketable securities as of September 30, 2026. This figure is an unaudited estimate released ahead of the company's full quarterly financial results.